Monoclonal antibody capable of recognizing arteriosclerotic lesions and agents for detecting and treating arteriosclerosis
CA 1308677 C · Owner: Hashida, Ryoichi · Inventors: Takano, Tatsuya; Nakagami, Keiji; Hashida, Ryoichi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Herein disclosed are a monoclonal antibody capable of preferentially recognizing arteriosclerotic lesions and prepared from a hybridoma obtained by fusing myeloma cells and cells capable of producing antibodies against arteriosclerotic lesions, such as spleen cells peripheral, lymphocyte of thymus and peripheral vascular cells the, antibody being able to use as an agent for detecting the presence of arteriosclerotic lesions in a body examined and for treating arteriosclerosis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted October 13, 1992. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended October 13, 2009.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.